Emergent Biosolutions
(EBS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 1,106,000 | 782,400 | 560,900 | 488,800 | 489,331 |
| Cost of Goods | 433,500 | 322,300 | 187,700 | 126,300 | 107,486 |
| Gross Profit | 672,500 | 460,100 | 373,200 | 362,500 | 381,845 |
| Operating Expenses | 558,900 | 370,600 | 249,600 | 257,300 | 240,817 |
| Operating Income | 114,100 | 89,800 | 124,300 | 105,500 | 141,514 |
| Interest Expense | 38,400 | 9,900 | 6,600 | 7,600 | 6,523 |
| Other Income | 1,700 | 1,600 | 900 | 1,300 | 725 |
| Pre-tax Income | 77,400 | 81,500 | 118,600 | 99,200 | 135,716 |
| Income Tax | 22,900 | 18,800 | 36,000 | 36,700 | 44,300 |
| Net Income Continuous | 54,500 | 62,700 | 82,600 | 62,500 | 91,416 |
| Net Income Discontinuous | N/A | N/A | N/A | -10,700 | -28,546 |
| Net Income | $54,500 | $62,700 | $82,600 | $51,800 | $62,870 |
| EPS Basic Total Ops | 1.06 | 1.25 | 1.98 | 1.29 | 1.63 |
| EPS Basic Continuous Ops | 1.06 | 1.25 | 1.98 | 1.56 | 2.37 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -0.27 | -0.74 |
| EPS Diluted Total Ops | 1.04 | 1.22 | 1.71 | 1.13 | 1.41 |
| EPS Diluted Continuous Ops | 1.04 | 1.22 | 1.64 | 1.35 | 2.02 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -0.22 | -0.61 |
| EPS Diluted Before Non-Recurring Items | 2.91 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $227,800 | $152,900 | $168,600 | $143,700 | $176,849 |